MEGAN C. TIMMINS Insider Profile
4 Followers
MEGAN C. TIMMINS, EVP, CLO & Secretary at Rockwell Med, holds 31.24K shares in Rockwell Med (Ticker: RMTI), holds 190.48K shares in Assertio Therapeutics (Ticker: ASRT), holds 0.00 shares in Zyla Life Sciences (Ticker: ZCOR).
MEGAN C. TIMMINS has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of MEGAN C. TIMMINS's holdings
Insider Roles
EVP, CLO & Secretary
Roles that MEGAN C. TIMMINS holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by MEGAN C. TIMMINS
MEGAN C. TIMMINS's Trading History
Rockwell Med
Jul 06, 2026
EVP, CLO & Secretary
Uninformative Buy
―
$270.23K
Egalet Corp
Feb 04, 2019
―
Uninformative Sell
―
$0.00
Zyla Life Sciences
May 21, 2020
―
Uninformative Sell
―
$0.00
Assertio Therapeutics
May 22, 2020
―
Uninformative Buy
―
$4.48M
List of latest transactions for each holding click on a transaction to see MEGAN C. TIMMINS's performance on stock
You May Also Like
MEGAN C. TIMMINS insider profile FAQ
What is the percentage of profitable transactions made by MEGAN C. TIMMINS?
The percentage of profitable transactions made by MEGAN C. TIMMINS is ―.
What is the average return per transaction made by MEGAN C. TIMMINS?
The average return per transaction made by MEGAN C. TIMMINS is ―.
What stocks does MEGAN C. TIMMINS hold?
MEGAN C. TIMMINS holds: RMTI, EGLTQ, ZCOR, ASRT stocks.
What was MEGAN C. TIMMINS’s latest transaction?
MEGAN C. TIMMINS latest transaction was an Uninformative Buy of ―.
What was MEGAN C. TIMMINS's most profitable transaction?
MEGAN C. TIMMINS’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is MEGAN C. TIMMINS's role in Rockwell Med?
MEGAN C. TIMMINS's role in Rockwell Med is EVP, CLO & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.